Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Cancer Program Earns CoC Accreditation With Commendation

Duke University Hospital’s NCI-Designated Comprehensive Cancer Program recently earned a three-year accreditation rating, with commendation , from the Commission on Cancer (CoC). Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated...

Metastatic Cancer Survivor Dismisses Fear; Embraces “Eye Of The Tiger”

Join us at facebook.com/dukecancerinstitute on Wednesday, May 1, at noon for a live panel discussion featuring cancer survivor and cycling enthusiast Tom Vibert, his oncologist John Strickler and Katie Sweet, senior manager of communications with The V Foundation for Cancer Research. Our own...

OHE To Host 50 Hoops

The Office of Health Equity (OHE) will host 50 Hoops , a panel discussion on barriers to enrollment in clinical trials, on Thursday, Nov. 8, from 5 to 6:30 p.m. in the Searle Center. A diverse panel made up of patients, caregivers and community members will anwer questions revolving around barriers...

Driver Launches Global Technology Platform

Driver, a global technology platform that connects cancer patients to the best treatments, recently launched in the United States and China. Driver’s platform enables any patient, anywhere in the world, to access from home treatment options across an unprecedented network of cancer centers...

Boulton Named Associate Director, Clinical Research Office and Business Operations

Susan Boulton, RN, BSN, previously assistant research practice manager (ARPM) with The Preston Robert Tisch Brain Tumor Center (PRTBTC), was recently named associate director for Duke Cancer Institute’s Clinical Research Office and Business Operations. “During her time with the brain tumor center,...

Honeycutt Teams With V Foundation In The Race For A Cure

After the loss of her dad, Don Painter, in 2014 to colon cancer, Wanda P. Honeycutt, RN, BSN, CCRP, began running. She participated in her first competitive race a year later when she took part in the 2015 CRUSH Colorectal 5K. That gateway competetive run led to her participation in several half...

Making Pigs Fly? Investigators Up To The Challenge

When Duke Cancer Institute researcher Christopher Pirozzi, PhD, was an intern doing stem cell research in Australia, he spotted a child’s mobile of a pig with wings in one of the director’s offices. He said it embodied exactly what research meant to him — making the seemingly impossible, possible...

Mobile Financial Assistance Tool in Development

Yousuf Zafar, MD, MHS, and healthcare technology company Vivor are the recent recipients of a National Institutes of Health/National Cancer Institute six-month grant of $224,997, which will fund initial development of a novel technology-based method designed to reduce cancer patients’ financial...

Poliovirus Trial for Pediatric Brain Tumors Funded

On Wednesday, Sept. 28, Matthias Gromeier, MD; Eric Thompson, MD; and Darell Bigner, MD, PhD; received a check for $208,408 from The Andrew McDonough B+ Foundation (The B+ Foundation) and Solving Kids’ Cancer (SKC) in honor of Steph Bader, a 13-year-old-girl who passed away from glioblastoma. The...

Duke’s Poliovirus Therapy Wins “Breakthrough” Status

The recombinant poliovirus therapy developed at the Preston Robert Tisch Brain Tumor Center at Duke Health has been granted “breakthrough therapy designation” from the U.S. Food and Drug Administration. The designation will expedite research into the poliovirus therapy, but it does not mean the...